Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
about
Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventionsBivalirudin versus heparin in patients undergoing percutaneous transcatheter aortic valve interventions: A systematic review and meta-analysis.Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face?Renal dysfunction and transcatheter aortic valve implantation outcomes.Adjuvant Antithrombotic Therapy in TAVR.Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial.Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudinSafety, efficiency and cost effectiveness of Bivalirudin: A systematic review.Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle.The current status of antiplatelet therapy in patients undergoing transcatheter aortic valve implantation.Thrombo-embolic prevention after transcatheter aortic valve implantation.Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.Transcatheter aortic valve replacement and stroke: a comprehensive review.Antithrombotic therapy in TAVI.
P2860
Q26740181-E61E461F-39C5-41EA-B641-8453DB35221BQ38612125-46362FAC-82DB-488A-833C-445B8D772792Q38645947-A33E5592-A349-4EC2-AE35-F7024F8308A3Q38820488-5468FA8F-56B7-44BF-A2BA-7BE7E19CDAB4Q38845954-8B9654C6-03FD-4AAA-8D8F-156CB7AC9F23Q40766317-6F883CC5-6692-4FB3-8CBC-C1DD8E7D4915Q41608793-C2701BAB-8C2E-451F-8207-2A6D0C8C69BCQ42707980-E8D824D6-2046-46F7-9C39-066E3B47382FQ47159836-0A8633C1-A0CD-4857-95CC-57C7BF4EAB48Q47160637-C9F3A5F8-B4E3-46E9-8E68-F987922C5E61Q47903684-32B9F87A-B0B2-4A1B-B382-745281C1F329Q48158581-97187EF3-C875-4B84-8F75-FF3A0D0CD397Q48333290-BA47349C-BA23-42DD-9EA1-E969FC09F9C3Q50054410-39239DD8-4670-41C4-8F32-9448E0E54191Q50054421-4066BD3B-4192-4235-9ECF-D54D4902FB5F
P2860
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bivalirudin Versus Heparin Ant ...... The Randomized BRAVO-3 Trial.
@en
type
label
Bivalirudin Versus Heparin Ant ...... The Randomized BRAVO-3 Trial.
@en
prefLabel
Bivalirudin Versus Heparin Ant ...... The Randomized BRAVO-3 Trial.
@en
P2093
P50
P1476
Bivalirudin Versus Heparin Ant ...... The Randomized BRAVO-3 Trial.
@en
P2093
Andreas Fach
Anita W Asgar
Antonio Colombo
Axel Linke
BRAVO-3 Investigators
Christian Hengstenberg
Christian Kupatt
Christophe Tron
David Hildick-Smith
Debra Bernstein
P304
P356
10.1016/J.JACC.2015.10.003
P407
P577
2015-10-08T00:00:00Z